(Q35075788)

6 August 2017

title

Predictors of an unsatisfactory response to pentavalent antimony in the treatment of American visceral leishmaniasis (English)

1 reference

6 August 2017

main subject

visceral leishmaniasis

1 reference

1 reference

Mácia A Santos

1

1 reference

6 August 2017

Raynério C Marques

2

1 reference

6 August 2017

Carolinne A Farias

3

1 reference

6 August 2017

Danielle M Vasconcelos

4

1 reference

6 August 2017

Jay M Stewart

5

1 reference

6 August 2017

Dorcas L Costa

6

1 reference

6 August 2017

Carlos H N Costa

7

1 reference

6 August 2017

publication date

1 November 2002

1 reference

Revista da Sociedade Brasileira de Medicina Tropical

6 August 2017

published in

1 reference

6 August 2017

volume

35

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

629-633

1 reference

A prospective study of visceral leishmaniasis in an endemic area of Brazil.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600014

Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600014

Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600014

Competence of the human host as a reservoir for Leishmania chagasi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600014

An urban outbreak of visceral leishmaniasis in Natal, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600014

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600014

QBC for the diagnosis of human and canine american visceral leishmaniasis: preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600014

Amphotericin versus pentamidine in antimony-unresponsive kala-azar

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600014

Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600014

Efficacy of amphotericin B in multi-drug resistant kala-azar in children in first decade of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600014

Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600014

10.1590/S0037-86822002000600014

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference